(Q43722886)

English

Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Tomari

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

T Shimoda

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

T Kawano

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

K Mitsuta

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Y Obase

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

C Fukushima

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

H Matsuse

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

S Kohno

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

156-161

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled budesonide and behavioural disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotrienes as Mediators of Airway Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotrienes are potent constrictors of human bronchi

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of synthetic leukotrienes on tracheal microvascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide clinical experience with the first marketed leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary eosinophilia associated with montelukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Churg-Strauss syndrome associated with zafirlukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962212-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62212-0

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

release_pe7zh6sd5bch3lmwankk77aj3m

1 reference

https://api.fatcat.wiki/v0/release/pe7zh6sd5bch3lmwankk77aj3m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43722886&oldid=2102841143"